Severe COVID-19 patients frequently develop acute respiratory distress syndrome (ARDS), with extra clinical manifestations including thromboembolic complications, dysfunctions of central or peripheral nervous system, and elevations of C-reactive protein (CRP) and IL-6 (6). This evidence concerns the gene CRP and acute respiratory distress syndrome.